LifePoint Health Company Profile (NASDAQ:LPNT)

About LifePoint Health (NASDAQ:LPNT)

LifePoint Health logoLifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities. Its services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services and pediatric services, and in some of its hospitals, the Company offers specialized services, such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. It provides outpatient services, such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Facilities
  • Symbol: NASDAQ:LPNT
  • CUSIP: 53219L10
  • Web:
  • Market Cap: $2.29464 billion
  • Outstanding Shares: 40,116,000
Average Prices:
  • 50 Day Moving Avg: $57.25
  • 200 Day Moving Avg: $61.82
  • 52 Week Range: $50.60 - $70.95
  • Trailing P/E Ratio: 12.81
  • Foreward P/E Ratio: 12.85
  • P/E Growth: 1.44
Sales & Book Value:
  • Annual Revenue: $6.42 billion
  • Price / Sales: 0.36
  • Book Value: $56.81 per share
  • Price / Book: 1.01
  • EBIDTA: $760.4 million
  • Net Margins: 2.61%
  • Return on Equity: 7.40%
  • Return on Assets: 2.66%
  • Debt-to-Equity Ratio: 1.24%
  • Current Ratio: 1.82%
  • Quick Ratio: 1.60%
  • Average Volume: 382,269 shs.
  • Beta: 0.85
  • Short Ratio: 13.42

Frequently Asked Questions for LifePoint Health (NASDAQ:LPNT)

What is LifePoint Health's stock symbol?

LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."

How were LifePoint Health's earnings last quarter?

LifePoint Health, Inc. (NASDAQ:LPNT) issued its quarterly earnings results on Tuesday, August, 1st. The company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.06. The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. LifePoint Health's revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.69 earnings per share. View LifePoint Health's Earnings History.

When will LifePoint Health make its next earnings announcement?

LifePoint Health is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for LifePoint Health.

What guidance has LifePoint Health issued on next quarter's earnings?

LifePoint Health issued an update on its FY17 earnings guidance on Tuesday, August, 1st. The company provided earnings per share (EPS) guidance of $3.92-$4.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.19. The company issued revenue guidance of $6.425-$6.500 billion, compared to the consensus revenue estimate of $6.55 billion.

Where is LifePoint Health's stock going? Where will LifePoint Health's stock price be in 2017?

13 equities research analysts have issued twelve-month price objectives for LifePoint Health's shares. Their predictions range from $59.00 to $77.00. On average, they expect LifePoint Health's share price to reach $65.50 in the next year. View Analyst Ratings for LifePoint Health.

What are analysts saying about LifePoint Health stock?

Here are some recent quotes from research analysts about LifePoint Health stock:

  • 1. According to Zacks Investment Research, "LifePoint Health’s stock has underperformed the industry year to date. Its focus on strategic growth through acquisition and integration of well-positioned hospitals in the growing areas of the U.S. have contributed to its top line growth. The company has also been divesting non-core operations to focus on core growth areas. Its sufficient cash enables the company to make acquisitions and buyback shares. Following second-quarter results, the company trimmed its 2017 guidance on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 60 days." (9/11/2017)
  • 2. Cantor Fitzgerald analysts commented, "We are reiterating our neutral rating and $55 price target, adjusting our 2017 adjusted EPS estimates and introducing 2018 estimates. Margins continue to be weak, and although we expect them to be relatively stable in 2017-18, our earnings outlook is generally lower than consensus and management's 2017 outlook. In our view, LPNT's acquisition strategy and joint venture have added some promising properties, but they are weighing on earnings as volumes remain disappointing." (2/21/2017)

Who are some of LifePoint Health's key competitors?

Who are LifePoint Health's key executives?

LifePoint Health's management team includes the folowing people:

  • William F. Carpenter III, Chairman of the Board, Chief Executive Officer
  • David M. Dill, President, Chief Operating Officer
  • Michael S. Coggin, Chief Financial Officer, Executive Vice President, Chief Accounting Officer
  • Victor Giovanetti, President — Eastern Group
  • Robert N. Klein, President — Western Group
  • R. Scott Raplee, President - Central Group
  • Melissa O. Waddey, President - Ambulatory and Operations Services
  • John P. Bumpus, Executive Vice President, Chief Administrative Officer
  • Jennifer C. Peters, Senior Vice President, General Counsel
  • Russell L. Holman M.D., Chief Medical Officer

Who owns LifePoint Health stock?

LifePoint Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.11%), Dimensional Fund Advisors LP (8.44%), American Century Companies Inc. (8.40%), Vanguard Group Inc. (8.25%), LSV Asset Management (4.97%) and Alliancebernstein L.P. (4.29%). Company insiders that own LifePoint Health stock include David M Dill, Gregory T Bier, John E D D S Maupin Jr, John P Bumpus, Richard H Evans and William F Carpenter III. View Institutional Ownership Trends for LifePoint Health.

Who sold LifePoint Health stock? Who is selling LifePoint Health stock?

LifePoint Health's stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., KBC Group NV, Russell Investments Group Ltd., BlackRock Inc., Prudential PLC, Hotchkis & Wiley Capital Management LLC, First Trust Advisors LP and Diamond Hill Capital Management Inc.. Company insiders that have sold LifePoint Health stock in the last year include David M Dill, John P Bumpus, Richard H Evans and William F Carpenter III. View Insider Buying and Selling for LifePoint Health.

Who bought LifePoint Health stock? Who is buying LifePoint Health stock?

LifePoint Health's stock was acquired by a variety of institutional investors in the last quarter, including LSV Asset Management, Victory Capital Management Inc., Bank of New York Mellon Corp, Brandywine Global Investment Management LLC, New Amsterdam Partners LLC NY, Prudential Financial Inc., Balyasny Asset Management LLC and WINTON GROUP Ltd. View Insider Buying and Selling for LifePoint Health.

How do I buy LifePoint Health stock?

Shares of LifePoint Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LifePoint Health's stock price today?

One share of LifePoint Health stock can currently be purchased for approximately $57.20.

MarketBeat Community Rating for LifePoint Health (NASDAQ LPNT)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  260 (Vote Outperform)
Underperform Votes:  389 (Vote Underperform)
Total Votes:  649
MarketBeat's community ratings are surveys of what our community members think about LifePoint Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for LifePoint Health (NASDAQ:LPNT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $65.50 (14.51% upside)

Analysts' Ratings History for LifePoint Health (NASDAQ:LPNT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/5/2017Royal Bank Of CanadaReiterated RatingBuy$77.00HighView Rating Details
6/6/2017Leerink SwannUpgradeMarket Perform -> Outperform$73.00 -> $74.00LowView Rating Details
6/6/2017Morgan StanleyInitiated CoverageEqual -> Equal Weight$65.00MediumView Rating Details
5/1/2017Barclays PLCBoost Price TargetEqual Weight$58.00 -> $60.00LowView Rating Details
4/4/2017Deutsche Bank AGInitiated CoverageHold -> Hold$68.00LowView Rating Details
3/27/2017MizuhoBoost Price TargetNeutral -> Neutral$57.00 -> $62.00MediumView Rating Details
2/21/2017Cantor FitzgeraldReiterated RatingNeutralN/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$62.00N/AView Rating Details
11/11/2016Credit Suisse GroupDowngradeOutperform -> Neutral$70.00 -> $60.00N/AView Rating Details
11/9/2016Avondale PartnersDowngradeOutperform -> Market PerformN/AView Rating Details
11/9/2016Bank of America CorporationDowngradeNeutral -> Underperform$66.00 -> $59.00N/AView Rating Details
10/25/2016Wolfe ResearchInitiated CoverageUnderperformN/AView Rating Details
9/30/2016Citigroup Inc.Reiterated RatingBuy$68.00N/AView Rating Details
8/2/2016Raymond James Financial, Inc.Lower Price TargetOutperform$75.00 -> $65.00N/AView Rating Details
8/1/2016WedbushReiterated RatingNeutral$80.00 -> $66.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
5/16/2016Robert W. BairdReiterated RatingBuyN/AView Rating Details
2/19/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$81.00 -> $77.00N/AView Rating Details
2/16/2016SunTrust Banks, Inc.Lower Price TargetNeutral$80.00 -> $72.00N/AView Rating Details
11/2/2015Oppenheimer Holdings, Inc.Reiterated RatingMarket PerformN/AView Rating Details
11/2/2015BMO Capital MarketsLower Price Target$81.00 -> $74.00N/AView Rating Details
10/19/2015Susquehanna Bancshares IncLower Price TargetNeutral$85.00 -> $75.00N/AView Rating Details
(Data available from 9/25/2015 forward)


Earnings History for LifePoint Health (NASDAQ:LPNT)
Earnings by Quarter for LifePoint Health (NASDAQ:LPNT)
Earnings History by Quarter for LifePoint Health (NASDAQ LPNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017$0.98N/AView Earnings Details
8/1/2017Q2 2017$0.90$0.96$1.64 billion$1.59 billionViewListenView Earnings Details
4/28/2017Q1 2017$1.01$1.07$1.64 billion$1.63 billionViewN/AView Earnings Details
2/17/2017Q4 2016$1.07$1.09$1.63 billion$1.61 billionViewN/AView Earnings Details
10/28/2016Q316$0.84$0.94$1.59 billion$1.59 billionViewListenView Earnings Details
7/29/2016Q216$0.90$0.71$1.61 billion$1.59 billionViewListenView Earnings Details
4/29/2016Q1$0.88$0.87$1.57 billion$1.58 billionViewListenView Earnings Details
2/12/2016Q415$1.06$1.11$1.39 billion$1.37 billionViewListenView Earnings Details
10/30/2015Q315$0.90$0.94$1.30 billion$1.31 billionViewListenView Earnings Details
7/31/2015Q215$0.98$1.00$1.24 billion$1.27 billionViewListenView Earnings Details
5/1/2015Q115$1.00$1.00$1.24 billion$1.26 billionViewListenView Earnings Details
2/12/2015Q414$1.01$1.08$1.25 billion$1.26 billionViewListenView Earnings Details
10/24/2014Q314$0.74$0.75$1.09 billion$1.38 billionViewListenView Earnings Details
7/25/2014Q214$0.55$0.84$1.01 billion$1.05 billionViewListenView Earnings Details
4/25/2014Q114$0.65$0.65$1,000.00 million$1.01 billionViewListenView Earnings Details
2/14/2014Q413$0.80$0.75$952.10 million$952.60 millionViewListenView Earnings Details
10/25/2013Q313$0.66$0.68$891.30 million$899.70 millionViewListenView Earnings Details
7/26/2013Q2 2013$0.72$0.65$911.08 million$894.90 millionViewListenView Earnings Details
4/26/2013Q1 2013$0.81$0.69$924.00 million$931.10 millionViewListenView Earnings Details
2/15/2013Q4 2012$0.65$0.76$863.49 million$893.30 millionViewListenView Earnings Details
10/26/2012Q312$0.76$0.39$814.52 million$820.20 millionViewN/AView Earnings Details
7/27/2012$0.80$0.83ViewN/AView Earnings Details
4/27/2012$0.91$0.94ViewN/AView Earnings Details
10/28/2011$0.71$0.77ViewN/AView Earnings Details
7/29/2011$0.75$0.77ViewN/AView Earnings Details
4/29/2011$0.81$0.89ViewN/AView Earnings Details
2/18/2011$0.67$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for LifePoint Health (NASDAQ:LPNT)
2017 EPS Consensus Estimate: $3.99
2018 EPS Consensus Estimate: $4.42
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$0.89$1.02$0.96
Q2 20175$0.88$0.98$0.94
Q3 20175$0.87$1.05$0.96
Q4 20175$1.03$1.26$1.12
Q1 20182$1.06$1.07$1.07
Q2 20182$1.02$1.05$1.04
Q3 20182$1.09$1.13$1.11
Q4 20182$1.19$1.22$1.21
Q2 20191$1.10$1.10$1.10
(Data provided by Zacks Investment Research)


Dividend History for LifePoint Health (NASDAQ:LPNT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for LifePoint Health (NASDAQ:LPNT)
Insider Ownership Percentage: 7.28%
Institutional Ownership Percentage: 99.53%
Insider Trades by Quarter for LifePoint Health (NASDAQ:LPNT)
Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)
Insider Trades by Quarter for LifePoint Health (NASDAQ:LPNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/17/2017William F Carpenter IIIChairmanSell17,653$65.06$1,148,504.18View SEC Filing  
6/15/2017William F Carpenter IIIChairmanSell82,347$64.15$5,282,560.05View SEC Filing  
5/11/2017Richard H EvansDirectorSell2,000$62.88$125,760.00View SEC Filing  
3/30/2017John P BumpusEVPSell33,333$65.00$2,166,645.00View SEC Filing  
3/16/2017David M DillInsiderSell18,800$62.22$1,169,736.00View SEC Filing  
3/10/2017David M DillInsiderSell1,200$65.00$78,000.00View SEC Filing  
3/9/2017John P BumpusEVPSell26,362$65.05$1,714,848.10View SEC Filing  
3/6/2017John P BumpusEVPSell305$65.00$19,825.00View SEC Filing  
5/25/2016John E D D S Maupin JrDirectorSell3,800$67.32$255,816.00View SEC Filing  
2/18/2016Gregory T BierDirectorSell2,149$63.00$135,387.00View SEC Filing  
5/7/2015Owen G Shell JrDirectorSell7,500$70.69$530,175.00View SEC Filing  
3/9/2015John E D D S Maupin JrDirectorSell1,300$72.50$94,250.00View SEC Filing  
2/23/2015Michael S CogginSVPSell5,000$70.50$352,500.00View SEC Filing  
9/9/2014Marguerite KondrackeDirectorSell1,500$72.43$108,645.00View SEC Filing  
7/31/2014Leif M MurphyCFOSell100,000$72.03$7,203,000.00View SEC Filing  
6/12/2014Richard H EvansDirectorSell1,000$64.05$64,050.00View SEC Filing  
5/16/2014William Carpenter IIICEOSell280,849$58.11$16,320,135.39View SEC Filing  
5/13/2014Paul GilbertEVPSell54,342$59.21$3,217,589.82View SEC Filing  
5/7/2014John BumpusEVPSell20,000$57.20$1,144,000.00View SEC Filing  
3/12/2014Marguerite KondrackeDirectorSell2,000$51.49$102,980.00View SEC Filing  
12/5/2013Paul GilbertEVPSell12,825$51.12$655,614.00View SEC Filing  
10/31/2013Michael S CogginSVPSell2,000$51.14$102,280.00View SEC Filing  
10/30/2013William F Carpenter IIICEOSell40,000$51.31$2,052,400.00View SEC Filing  
8/1/2013Michael CogginSVPSell2,452$50.00$122,600.00View SEC Filing  
6/6/2013Paul D GilbertEVPSell16,667$51.01$850,183.67View SEC Filing  
5/20/2013Richard H EvansDirectorSell4,275$47.50$203,062.50View SEC Filing  
2/25/2013Michael S CogginSVPSell6,668$44.03$293,592.04View SEC Filing  
2/25/2013Richard H EvansDirectorSell5,000$43.31$216,550.00View SEC Filing  
9/14/2012Marguerite SalleeDirectorSell3,000$42.36$127,080.00View SEC Filing  
8/21/2012Michael S CogginSVPSell6,666$41.00$273,306.00View SEC Filing  
8/21/2012William F Carpenter IIICEOSell50,000$41.02$2,051,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for LifePoint Health (NASDAQ:LPNT)
Latest Headlines for LifePoint Health (NASDAQ:LPNT)
DateHeadline logoHead-To-Head Contrast: LifePoint Health (LPNT) versus The Joint Corp. (JYNT) - September 23 at 2:32 PM logoShould You Buy LifePoint Health Inc (LPNT) Now? - September 23 at 6:08 AM logoResearch Analysts Issue Forecasts for LifePoint Health, Inc.'s Q2 2019 Earnings (LPNT) - September 18 at 8:46 AM logoLifePoint Health, Inc. (LPNT) Expected to Post Quarterly Sales of $1.60 Billion - September 16 at 9:11 AM logoLifePoint Health (LPNT) versus Chemed Corp. (CHE) Critical Review - September 14 at 8:28 PM logoLifePoint Health, Inc. (LPNT) Given Average Rating of "Hold" by Analysts - September 12 at 12:48 PM logoLifePoint Health (LPNT) Down 4.8% Since Earnings Report: Can It Rebound? - September 11 at 10:52 PM logoLifePoint Health, Inc. (LPNT) Raised to "Hold" at Zacks Investment Research - September 11 at 1:56 PM logoZacks Investment Research Lowers LifePoint Health, Inc. (LPNT) to Sell - September 5 at 1:32 PM logoComparing LifePoint Health (LPNT) and TeamHealth Holdings (TMH) - September 4 at 4:28 AM logoLifePoint Health, Inc. (LPNT) Downgraded to Hold at ValuEngine - September 2 at 10:34 PM logoComparing LifePoint Health (LPNT) & HealthStream (HSTM) - September 1 at 12:20 PM logoLifePoint Health to Participate in Baird 2017 Healthcare Conference - September 1 at 2:42 AM logoLifePoint Health to Participate in the 2017 Wells Fargo Healthcare Conference - August 31 at 6:58 AM logoZacks Investment Research Downgrades LifePoint Health, Inc. (LPNT) to Sell - August 29 at 10:54 AM logoReviewing Tenet Healthcare Corporation (THC) & LifePoint Health (LPNT) - August 28 at 10:44 AM logoZacks: Brokerages Anticipate LifePoint Health, Inc. (LPNT) Will Announce Quarterly Sales of $1.60 Billion - August 28 at 1:30 AM logoFinancial Contrast: American Renal Associates Holdings (ARA) and LifePoint Health (LPNT) - August 25 at 2:10 PM logoSurprising Analyst 12-Month Target For FXH - August 21 at 7:40 PM logoLifePoint Health, Inc. (LPNT) Upgraded to Hold at Zacks Investment Research - August 21 at 1:38 PM logoLifePoint Health, Inc. (LPNT) Lowered to "C+" at TheStreet - August 19 at 10:54 PM logoHere's Why Investors Should Offload LifePoint (LPNT) Stock - August 19 at 2:47 AM logoLifePoint Health, Inc. (LPNT) Receives Average Rating of "Hold" from Analysts - August 18 at 12:48 PM logoValuEngine Upgrades LifePoint Health, Inc. (LPNT) to "Buy" - August 17 at 11:20 PM logo$1.60 Billion in Sales Expected for LifePoint Health, Inc. (NASDAQ:LPNT) This Quarter - August 10 at 7:44 AM logoLifePoint Health, Inc. to Post FY2018 Earnings of $4.60 Per Share, Cantor Fitzgerald Forecasts (LPNT) - August 9 at 1:42 PM logo$0.96 Earnings Per Share Expected for LifePoint Health, Inc. (NASDAQ:LPNT) This Quarter - August 8 at 2:18 PM logoLifePoint Health, Inc. – Value Analysis (NASDAQ:LPNT) : August 7, 2017 - August 7 at 8:54 PM logoQ3 2017 Earnings Estimate for LifePoint Health, Inc. Issued By KeyCorp (NASDAQ:LPNT) - August 7 at 7:40 AM logoFY2019 Earnings Forecast for LifePoint Health, Inc. Issued By SunTrust Banks (LPNT) - August 4 at 7:40 PM logoLeerink Swann Weighs in on LifePoint Health, Inc.'s Q3 2017 Earnings (LPNT) - August 4 at 7:16 AM logoLifePoint Health, Inc. (NASDAQ:LPNT) Expected to Earn FY2018 Earnings of $4.50 Per Share - August 3 at 3:30 PM logoSunTrust Banks Equities Analysts Decrease Earnings Estimates for LifePoint Health, Inc. (NASDAQ:LPNT) - August 3 at 8:00 AM logoResearch Analysts Set Expectations for LifePoint Health, Inc.'s Q3 2017 Earnings (LPNT) - August 3 at 8:00 AM logoLifePoint Health Reports Second Quarter 2017 Results - August 3 at 3:30 AM logo-Hospital operator LifePoint's quarterly profit more than doubles - August 3 at 3:30 AM logoEdited Transcript of LPNT earnings conference call or presentation 1-Aug-17 2:00pm GMT - August 3 at 3:30 AM logoLifePoint Health, Inc. to Post Q4 2017 Earnings of $1.03 Per Share, Oppenheimer Holdings Forecasts (LPNT) - August 2 at 1:14 PM logoLifePoint Health (LPNT) Q2 2017 Results - Earnings Call Transcript - August 2 at 3:20 AM logoLifePoint beats 2Q profit forecasts - August 2 at 3:20 AM logoLifePoint Health, Inc. (LPNT) Announces Earnings Results - August 1 at 10:47 AM logoLifePoint Health, Inc. (LPNT) Releases FY17 Earnings Guidance - August 1 at 9:39 AM logoLifePoint Health, Inc. breached its 50 day moving average in a Bearish Manner : LPNT-US : July 26, 2017 - July 27 at 4:02 AM logoLifePoint Health, Inc. (LPNT) Receives Average Recommendation of "Hold" from Brokerages - July 24 at 12:11 PM logoLifePoint Health, Inc. (LPNT) Expected to Announce Quarterly Sales of $1.63 Billion - July 21 at 7:56 PM logoLifePoint Health, Inc. (LPNT) Chairman Sells $1,148,504.18 in Stock - July 19 at 7:16 PM logoZacks: Analysts Anticipate LifePoint Health, Inc. (LPNT) Will Announce Earnings of $0.90 Per Share - July 19 at 12:21 PM logoLifePoint Health To Broadcast Its Second Quarter 2017 Conference Call Live On The Internet - July 18 at 10:02 PM logoWhy More Limbo on Healthcare Reform Is Bad News for Hospital Stocks - July 18 at 5:01 PM logoLeerink Swann Analysts Boost Earnings Estimates for LifePoint Health, Inc. (LPNT) - July 14 at 9:16 AM



LifePoint Health (LPNT) Chart for Monday, September, 25, 2017

This page was last updated on 9/25/2017 by Staff